Lan Huang

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database
    Lan Huang
    Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    J Biopharm Stat 23:178-200. 2013
  2. pmc A scan statistic for continuous data based on the normal probability model
    Martin Kulldorff
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    Int J Health Geogr 8:58. 2009
  3. pmc A modified version of Moran's I
    Monica C Jackson
    Department of Mathematics and Statistics, 4400 Massachusetts Ave NW, American University, Washington, DC 20016, USA
    Int J Health Geogr 9:33. 2010
  4. doi request reprint Population-based survival-cure analysis of ER-negative breast cancer
    Lan Huang
    CDER OB DBV, Food and Drug Administration, 10903 New Hampshire Avenue, Building 21, Rm 3629, Silver Spring, MD 20993 0002, USA
    Breast Cancer Res Treat 123:257-64. 2010
  5. doi request reprint Covariate adjusted weighted normal spatial scan statistics with applications to study geographic clustering of obesity and lung cancer mortality in the United States
    Lan Huang
    Office of Biostatistics, CDER, FDA, Silver Spring, MD 20993, USA
    Stat Med 29:2410-22. 2010
  6. doi request reprint Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries
    Lan Huang
    FDA CDER, 10903 New Hampshire Ave, Bldg 21, Silver Spring, MD 20993, USA
    Biom J 55:755-70. 2013

Collaborators

Detail Information

Publications6

  1. doi request reprint Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database
    Lan Huang
    Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    J Biopharm Stat 23:178-200. 2013
    ....
  2. pmc A scan statistic for continuous data based on the normal probability model
    Martin Kulldorff
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    Int J Health Geogr 8:58. 2009
    ..It may also be used for other distributions, while still maintaining the correct alpha level. In an application of the new method, we look for geographical clusters of low birth weight in New York City...
  3. pmc A modified version of Moran's I
    Monica C Jackson
    Department of Mathematics and Statistics, 4400 Massachusetts Ave NW, American University, Washington, DC 20016, USA
    Int J Health Geogr 9:33. 2010
    ..We compare our modified Moran's I with Oden's I*pop for simulated data with homogeneous populations. The proposed method is applied to a census tract data set...
  4. doi request reprint Population-based survival-cure analysis of ER-negative breast cancer
    Lan Huang
    CDER OB DBV, Food and Drug Administration, 10903 New Hampshire Avenue, Building 21, Rm 3629, Silver Spring, MD 20993 0002, USA
    Breast Cancer Res Treat 123:257-64. 2010
    ..We notice that at age >o5r=70, the accelerated increase in cure fraction from 1992 to 1998 for women with stage II N+ compared with stage III suggests a selective benefit for chemotherapy in the lower stage group...
  5. doi request reprint Covariate adjusted weighted normal spatial scan statistics with applications to study geographic clustering of obesity and lung cancer mortality in the United States
    Lan Huang
    Office of Biostatistics, CDER, FDA, Silver Spring, MD 20993, USA
    Stat Med 29:2410-22. 2010
    ....
  6. doi request reprint Adjusting for reporting delay in cancer incidence when combining different sets of cancer registries
    Lan Huang
    FDA CDER, 10903 New Hampshire Ave, Bldg 21, Silver Spring, MD 20993, USA
    Biom J 55:755-70. 2013
    ..We use the method to obtain delay-adjusted incidence rates for melanoma, liver cancer, and Hodgkin lymphoma. ..